Emmessar Biotech & Nutrition informs about disclosure

19 Dec 2019

Emmessar Biotech & Nutrition has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Emmessar Technologies.

The above information is a part of company’s filings submitted to BSE.


Related Emmessar Biotech & Nutrition Ltd. Links:

Emmessar Biotech&Nut Share Price

17.45 -0.90 (-4.90%) Feb 26, 18:55
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 595.30
Dr. Reddys Lab 4424.60
Lupin 1018.50
Piramal Enterprises 1828.50
Cadila Healthcare 434.75
View more..
Sensex vs Emmessar Biotech&Nut
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback